Macrophage labeling by SPIO as an early marker of allograft chronic rejection in a rat model of kidney transplantation

Magnetic Resonance in Medicine

Volumn 49, Issue 3, 2003, Pages 459-467

  Beckmann, Nicolau ^a   Cannet, C ^a   Fringeli Tanner, M ^a   Baumann, D ^a   Pally, C ^a   Bruns, C ^a   Zerwes, H G ^a   Andriambeloson, E ^a   Bigaud, M ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Cell labeling; Chronic rejection; Kidney; Macrophages; Magnetic resonance imaging; Rapamycin; Renography; SPIO; Transplantation; USPIO

Indexed keywords

ARTIFICIAL LIFE; IRON OXIDES; MAGNETIC RESONANCE IMAGING; RATS; TRANSPLANTATION (SURGICAL);

CELL LABELING; CHRONIC REJECTION; KIDNEY; RAPAMYCIN; RENOGRAPHY; SPIO; USPIO;

MACROPHAGES;

CYCLOSPORIN; CYCLOSPORIN A; EVEROLIMUS; GADOTERIC ACID; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; GRAFT REJECTION; IMMUNOMODULATION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MACROPHAGE; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; RENOGRAPHY; SIGNAL PROCESSING;

EID: 0344520474     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.10387     Document Type: Article

References (40)

1. Duijvestijn AM, van Breda Vriesman PJ. Chronic renal allograft rejection. Selective involvement of the glomerular endothelium in humoral immune reactivity and intravascular coagulation. Transplantation 1991;52:195-202.
2. de Heer E, Davidoff A, van der Wal A, van Geest M, Paul LC. Chronic renal allograft rejection in the rat. Transplantation-induced antibodies against basement membrane antigens. Lab Invest 1994;70:494-502.
3. Cook NS, Zerwes H-G, Rudin M, Beckmann N, Schuurman H-J. Chronic graft loss: dealing with the vascular alterations in solid organ transplantation. Transplant Proc 1998;30:2413-2418.
4. Olsen TS. Pathology of allograft rejection. In: Burdick JF, Racusen LC, Solez K, Williams GM, editors. Kidney transplant rejection: diagnosis and treatment. New York: Marcel Dekker; 1991. p 333.
5. Schuurman H-J, Weckbecker G, Bruns C, Beckmann N, Rudin M, Cook NS. Preclinical models of chronic rejection: promises and pitfalls. Transplant Proc 1997;29:2624-2625.
6. Azuma H, Heemann U, Tullius SG, Tilney NL. Host leukocytes and their products in chronic kidney allograft rejection in rats. Transpl Int 1994;7(Suppl 1):S325-S327.
7. Junaid A, Kren SM, Rosenberg ME, Nath KA, Hostetter TH. Physiological and structural responses to chronic experimental renal allograft injury. Am J Physiol 1994;267:F1102-F1106.
8. Beckmann N, Hof RP, Rudin M. The role of magnetic resonance imaging and spectroscopy in transplantation: from animal models to man. NMR Biomed 2000;13:329-348.
9. Beckmann N, Joergensen J, Bruttel K, Rudin M, Schuurman H-J. Magnetic resonance imaging for the evaluation of rejection of a kidney allograft in the rat. Transpl Int 1996;9:175-183.
10. Gaschen L, Schuurman H-J, Bruttel K, Tanner M, Beckmann N. MRI and ultrasonographic detection of morphologic and hemodynamic changes in chronic renal allograft rejection in the rat. J Magn Reson Imag 2001;13:232-241.
11. Yang D, Ye Q, Williams M, Sun Y, Hu TC-C, Williams DS, Moura JMF, Ho C. USPIO-enhanced dynamic MRI: evaluation of normal and transplanted rat kidneys. Magn Reson Med 2001;46:1152-1163.
12. Sharma RK, Gupta RK, Poptani H, Pandey CM, Gujral RB, Bhandari M. The magnetic resonance renogram in renal transplant evaluation using dynamic contrast-enhanced MR imaging. Radiology 1995;59:1405-1409.
13. Baumann D, Rudin M. Quantitative assessment of rat kidney function by measuring the clearance of the contrast agent Gd(DOTA) using dynamic MRI. Magn Reson Imag 2000;18:587-595.
14. Laurent D, Poirier K, Wasvary J, Rudin M. Effect of essential hypertension on kidney function as measured in rat by dynamic MRI. Magn Reson Med 2002;47:127-134.
15. Southard JH, van Gulik TM, Ametani MS, Vreugdenhil PK, Lindell SL, Pienaar BL, Belzer FO. Important components of the UW solution. Transplantation 1990;49:251-257.
16. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with contrast agents. Magn Reson Med 1990;14:249-265.
17. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999;55:713-723.
18. Mahabir RN, Guttmann RD, Lindquist RR. Renal transplantation in the inbred rat. X. A model of "weak histoincompatibility" by major locus matching. Transplantation 1969;8:369-378.
19. White E, Hildeman WH, Mullen Y. Chronic kidney allograft reactions in rats. Transplantation 1969;8:602-617.
20. Diamond JR, Tilney NL, Frye J, Ding G, McElroy J, Pesek-Diamond I, Yang H. Progressive albuminuria and glomerulosclerosis in a rat model of chronic renal allograft rejection. Transplantation 1992;54:710-716.
21. Koushanpour E, Kriz W. Renal physiology. New York: Springer; 1986. p 132-239.
22. Olsen S, Spencer E, Cockburn S, Marcussen N, Solez K, Endocapillary glomerulitis in the renal allograft. Transplantation 1995;59:1421-1425.
23. Weissleder R, Elizondo G, Wittenberg J, Rabito C, Bengele H, Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990;175:489-493.
24. Weissleder R, Elizondo G, Wittenberg J, Lee AS, Brady TJ, Josephson L. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 1990;175:494-498.
25. Dousset V, Delalande C, Ballarino L, Quesson B, Seilhan D, Coussemacq M, Thiaudière E, Brochet B, Canioni P, Caille JM. In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance. Magn Reson Med 1999;41:329-333.
26. Rausch M, Sauter A, Fröhlich J, Neubacher U, Radü EW, Rudin M. Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage. Magn Reson Med 2001;46:1018-1022.
27. Hauger O, Delalande C, Trillaud H, Deminiere C, Quesson B, Kahn H, Cambar J, Combe C, Grenier N. MR imaging of intrarenal macrophage infiltration in an experimental model of nephrotic syndrome. Magn Reson Med 1999;41:156-162.
28. Poston RS, Billingham M, Hoyt EG, Pollard J, Shorthouse R, Morris RE, Robbins RC. Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model. Circulation 1999;100:67-74.
29. Viklicky O, Zou H, Muller V, Lacha J, Szabo A, Heemann U. SDZ-RAD prevents manifestation of chronic rejection in rat renal allografts. Transplantation 2000;27:497-502.
30. Nashan B. Early clinical experience with a novel rapamycin derivative. Ther Drug Monit 2002;24:53-58.
31. Nadasdy T, Krenacs T, Kalmar KN, Csajbok E, Bouda K, Ormos J. Importance of plasma cells in the infiltration of renal allografts: an immunohistological study. Pathol Res Pract 1991;187:178-183.
32. Zhang Y, Dodd SJ, Hendrich KS, Williams M, Ho C. Magnetic resonance imaging detection of rat renal transplant rejection by monitoring macrophage infiltration. Kidney Int 2000;58:1300-1310.
33. Kanno S, Lee PC, Dodd SJ, Williams M, Griffith BP, Ho C. A novel approach with magnetic resonance imaging used for the detection of lung allograft rejection. J Thorac Cardiovasc Surg 2000;120:923-934.
34. Kanno S, Wu YJ, Lee PC, Dodd SJ, Williams M, Griffith BP, Ho C. Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation 2001;104:934-938.
35. Paul LC, Grothman GT, Benediktsson H, Davidoff A, Rozing J. Macrophage subpopulations in normal and transplanted heart and kidney tissues in the rat. Transplantation 1992;53:157-162.
36. Beckmann N, Tigani B, Ekatodramis D, Borer R, Mazzoni L, Fozard JR. Pulmonary edema induced by allergen challenge in the rat: non-invasive assessment by magnetic resonance imaging. Magn Reson Med 2001;45:88-95.
37. Beckmann N, Gentsch C, Baumann D, Bruttel K, Vassout A, Schoeffter P, Loetscher E, Bobadilla M. Perentes E, Rudin M. Non-invasive, quantitative assessment of the anatomical phenotype of corticotropin-releasing factor overexpressing mice by MRI. NMR Biomed 2001;14:210-216.
38. Beckmann N, Mueggler T, Allegrini PR, Laurent D, Rudin M. From anatomy to the target: contributions of magnetic resonance imaging to pre-clinical pharmaceutical research. Anat Rec (New Anat) 2001;265:85-100.
39. Schuurman H-J, Beckmann N, Briner U, Bruns C, Bruttel K, Tanner M, Tolcsvai L, Weckbecker G. Chronic rejection of a rat kidney allograft: value of magnetic resonance imaging to assess the graft status and the effect of the somatostatin analogue SMS 201-995. Transplant Proc 1996;28:3272-3275.
40. Weckbecker G, Pally C, Raulf F, Beckmann N, Schuurman H-J, Rudin M, Bruns C. The somatostatin analog octreotide as potential treatment for re-stenosis and chronic rejection. Transplant Proc 1997;29:2599-2600.